HomeInsightsBoard of Directors

Glaxosmithkline Pharmaceuticals Ltd Board of Directors

Glaxosmithkline Pharmaceuticals Ltd Board of Directors

stocks purchased

₹ 1.4 Cr

Volume transacted

stocks purchased

5.1 K

stocks traded

Last Updated time: 19 Sep 9.00 AM

Board of Directors

name
leftdesignationleft
D SundaramIndependent Director
A A NadkarniCompany Sec. & Compli. Officer
P V BhideIndependent Director
A N RoyIndependent Director
Subesh WilliamsNon Executive Director

Key Highlights

  • D Sundaram continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
  • A A Nadkarni continues to serve as the Company Sec. & Compli. Officer in 2024, maintaining the same position as in the previous year.
  • P V Bhide continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
  • A N Roy continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
  • Subesh Williams joins the board as Non Executive Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

PRICE

stock direction

Last updated:

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 20242698.95
18 Sep 20242795.2
17 Sep 20242800
16 Sep 20242830
13 Sep 20242903.1
12 Sep 20242861.95
11 Sep 20242855.35
10 Sep 20242817.9
09 Sep 20242848.95
06 Sep 20242831.25

Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd

Market Cap

45,721 Cr

EPS

45.5

P/E Ratio (TTM) *

59.4

P/B Ratio (TTM) *

25.7

Day’s High *

2795.0

Day’s Low

2677.0

DTE *

0.0

ROE *

38.9

52 Week High

3087.95

52 Week Low

1387.9

ROCE *

53.5

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Glaxosmithkline Pharmaceuticals Ltd News Hub

News

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarte...

Read more

03 Aug 202412:25

News

GlaxoSmithKline Pharmaceuticals to convene board meeting

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

18 Jul 202410:38

News

Glaxosmithkline Pharmaceuticals announces change in senior management

Glaxosmithkline Pharmaceuticals announced that Dr. Shalini Menon has been appointed as Exe...

Read more

05 Jul 202413:26

News

Glaxosmithkline Pharmaceuticals Ltd leads losers in 'A' group

Som Distilleries & Breweries Ltd, Godfrey Phillips India Ltd, Confidence Petroleum India L...

Read more

03 Jun 202415:00

News

Board of GlaxoSmithKline Pharmaceuticals recommends Final Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at it...

Read more

17 May 202414:03

News

GlaxoSmithKline Pharmaceuticals to conduct AGM

GlaxoSmithKline Pharmaceuticals announced that the 99th Annual General Meeting(AGM) of the...

Read more

17 May 202416:48

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

May 2024

Transcript

Mar 2023

Transcript

Aug 2021

PPT

Feb 2020

PPT

FAQs for Board of Directors of Glaxosmithkline Pharmaceuticals Ltd

How are members of Glaxosmithkline Pharmaceuticals Ltd Board of Directors selected?

Members of the Glaxosmithkline Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Glaxosmithkline Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Glaxosmithkline Pharmaceuticals Ltd Board of Directors?

Shareholders can interact with the Glaxosmithkline Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Glaxosmithkline Pharmaceuticals Ltd Board of Directors meet?

The Glaxosmithkline Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Glaxosmithkline Pharmaceuticals Ltd Board of Directors?

The Glaxosmithkline Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Glaxosmithkline Pharmaceuticals Ltd?

The current Board of Directors at Glaxosmithkline Pharmaceuticals Ltd includes D Sundaram( Independent Director) ,A A Nadkarni( Company Sec. & Compli. Officer) ,P V Bhide( Independent Director) ,A N Roy( Independent Director) ,Subesh Williams( Non Executive Director) . The full list can be found on Glaxosmithkline Pharmaceuticals Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*